设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
SpringerLink电子期刊(7)
Elsevier电子期刊(6)
在“
Elsevier电子期刊
”中,
命中:
6
条,耗时:小于0.01 秒
在所有数据库中总计命中:
13
条
1.
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
作者:
Prof Andreas du Bois
;
MD
a
;
prof.dubois@googlemail.com" class="auth_mail" title="E-mail the corresponding author
;
Prof Gunnar Kristensen
;
PhD
b
;
Prof Isabelle Ray-Coquard
;
MD
c
;
Alexander Reuss
;
MSc
d
;
Sandro Pignata
;
MD
e
;
Prof Nicoletta Colombo
;
MD
f
;
g
;
Ursula Denison
;
MD
h
;
Prof Ignace Vergote
;
MD
i
;
Jose M del Campo
;
MD
j
;
Petronella Ottevanger
;
PhD
k
;
Martin Heubner
;
MD
l
;
Thomas Minarik
;
PhD
m
;
Emmanuel Sevin
;
MD
n
;
Nikolaus de Gregorio
;
MD
o
;
Prof Mariusz Bidziński
;
MD
p
;
Prof Jacobus Pfisterer
;
MD
q
;
Susanne Malander
;
MD
r
;
Prof
Felix
Hilpert
;
MD
s
;
Mansoor R Mirza
;
MD
t
;
Prof Giovanni Scambia
;
MD
u
;
Prof Werner Meier
;
MD
v
;
Maria O Nicoletto
;
MD
w
;
Prof Line Bjø
;
rge
;
PhD
x
;
Alain Lortholary
;
MD
y
;
Martin Oliver Sailer
;
PhD
z
;
Michael Merger
;
MD
z
;
Philipp Harter
;
MD
a
;
on behalf of the AGO Study Group led Gynecologic Cancer Intergroup (GCIG)/European Network of Gynaecologic Oncology Trials Groups (ENGOT) Intergroup Consortium
刊名:The Lancet Oncology
出版年:2016
2.
Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trial
作者:
Dr Christina H Ruhlmann
;
PhD
a
;
c.ruhlmann@dadlnet.dk" class="auth_mail" title="E-mail the corresponding author
;
Thomas Broe Christensen
;
PhD
b
;
Line Hammer Dohn
;
PhD
c
;
Merete Paludan
;
MD
d
;
Eva Rø
;
nnengart
;
RN
b
;
Ulrich Halekoh
;
PhD
e
;
Felix
Hilpert
;
MD
g
;
Prof Petra Feyer
;
MD
h
;
Prof Gunnar Kristensen
;
PhD
i
;
Prof Olfred Hansen
;
PhD
a
;
f
;
Prof Dorothy Keefe
;
MD
j
;
Prof Jø
;
rn Herrstedt
;
DMSc
a
;
f
刊名:The Lancet Oncology
出版年:2016
3.
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial
作者:
Dr Dan Stark
;
FRCP
a
;
d.p.stark@leeds.ac.uk
;
Matthew Nankivell
;
MSc
b
;
Prof Eric Pujade-Lauraine
;
MD
c
;
Gunnar Kristensen
;
MD
d
;
Lorraine Elit
;
MD
e
;
Martin Stockler
;
MBBS
f
;
g
;
Felix
Hilpert
;
MD
h
;
André
;
s Cervantes
;
MD
i
;
Julia Brown
;
MSc
a
;
Anne Lanceley
;
PhD
j
;
Prof Galina Velikova
;
MD
a
;
Eduardo Sabate
;
MD
k
;
Prof Jacobus Pfisterer
;
MD
l
;
Mark S Carey
;
MD
m
;
Philip Beale
;
MBBS
f
;
Wendi Qian
;
PhD
n
;
Ann Marie Swart
;
MRCP
b
;
Amit Oza
;
FRCP
o
;
Tim Perren
;
MD
p
刊名:Lancet Oncology
出版年:2013
4.
Mammary fibroblasts regulate morphogenesis of normal and tumorigenic breast epithelial cells by mechanical and paracrine signals
作者:
Inke L¨¹hr
;
Andreas Friedl
;
Thorsten Overath
;
Andreas Tholey
;
Thomas Kunze
;
Felix
Hilpert
;
Susanne Sebens
;
Norbert Arnold
;
Frank R?sel
;
Hans-Heinrich Oberg
;
Nicolai Maass
;
Christoph Mundhenke
;
Walter Jonat
;
Maret Bauer
关键词:
Mammary fibroblasts
;
Microenvironment
;
Breast cancer
;
Acinar morphogenesis
;
Matrix compliance
刊名:Cancer Letters
出版年:2012
5.
Advanced disease — the optimal sequential treatment strategy
作者:
Walter Jonat
;
Felix
Hilpert
关键词:
Metastatic breast cancer
;
Gemcitabine plus docetaxel
;
Capecitabine plus docetaxel
刊名:European Journal of Cancer Supplements
出版年:2005
6.
Clinical picture: Nail changes secondary to docetaxel
作者:
Wasner
;
Gunnar
;
Hilpert
;
Felix
;
Baron
;
Ralf
;
Pfisterer
;
Jacobus
刊名:The Lancet
出版年:2001
1
按检索点细分(6)
作者(6)
按出版年细分(6)
2016年(2)
2013年(1)
2012年(1)
2005年(1)
2001年(1)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.